-+ 0.00%
-+ 0.00%
-+ 0.00%

Eli Lilly: The base will focus on developing oral GLP-1 drug ofoglitide.

Zhitongcaijing·12/09/2025 20:41:33
Listen to the news
Eli Lilly: The base will focus on developing oral GLP-1 drug ofoglitide.